51662-1555Level 3
HYALURONIDASE (HYALURONIDASE)
**Product type:** Human Prescription Drug
**Active ingredient:** HYALURONIDASE (HUMAN RECOMBINANT)
**Strength:** 150 [USP'U]/mL
**Dosage form:** Injection, Solution
**Route:** Subcutaneous
**Labeler:** HF Acquisition Co LLC, DBA HealthFirst
**Marketing category:** BLA (BLA021859)
**Pharmacologic class:** Endoglycosidase [EPC], Glycoside Hydrolases [CS]
GET
/api/v1/systems/ndc_fda/nodes/51662-1555Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.